inVentiv closes i3 deal
13 June 2011 | Jonathan Hare Scrip Clinical Research
INTERVIEW: Creative healthcare solutions keep Toshiba among the leaders Interview: Mundipharma's emerging markets architect on growth in China and opioid regs BioNotebook: Blend raises VC cash; Actavis gets quick Namenda appeal; and three new deals Fudged ECG reports: GVK blunder or overblown storm?
Other Features & Analysis
Expert view: Navigating the changing landscape of transfer pricing Conducting drug clinical trials in Russia: today and what lies ahead US regulations for drugs and devices - the shape of things to come Scrip100: Indian firms up R&D spend, ascend value chain